Espironolactona (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Espironolactona" in Catalan language version.

refsWebsite

Global rank Catalan rank

4^th place

7^th place

1^st place

2^nd place

6^th place

low place

2,374^th place

2,440^th place

low place

aemps.es

«Fitxa tècnica de l'espironolactona» (en castellà). CIMA AEMPS. [Consulta: 31 agost 2019].

Pitt B, Zannad F, Remme W, Cody R, Castaigne A, Perez A, Palensky J, Wittes J «The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.». N Engl J Med, 341, 10, 1999, pàg. 709-17. Arxivat de l'original el 2006-08-10. DOI: 10.1056/NEJM199909023411001. PMID: 10471456 [Consulta: 31 agost 2019].
Verhamme KMC, Mosis G, Dieleman JP, et al. «Spironolactone and risk of upper gastrointestinal events: population based case-control study». Brit Med J, 333, 7563, 2006, pàg. 330–3. DOI: 10.1136/bmj.38883.479549.2F.

«Advisory Statement». Klinge Chemicals / LoSalt. Arxivat de l'original el 2006-11-15. [Consulta: 15 març 2007].

Berardesca, E; Gabba P; Ucci G; Borroni G; Rabbiosi G. «Topical spironolactone inhibits dihydrotestosterone receptors in human sebaceous glands: an autoradiographic study in subjects with acne vulgaris.». Int J Tissue React, 10, 2, 1988, pàg. 115-119. PMID: 2972662 [Consulta: 15 març 2007].
Pitt B, Zannad F, Remme W, Cody R, Castaigne A, Perez A, Palensky J, Wittes J «The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.». N Engl J Med, 341, 10, 1999, pàg. 709-17. Arxivat de l'original el 2006-08-10. DOI: 10.1056/NEJM199909023411001. PMID: 10471456 [Consulta: 31 agost 2019].
Wandelt-Freerksen E. «Aldactone in the treatment of sarcoidosis of the lungs». JZ Erkr Atmungsorgane., 149(1), 1977, pàg. 156-9. PMID: 607621 [Consulta: 2 maig 2007].

Pitt B, Zannad F, Remme W, Cody R, Castaigne A, Perez A, Palensky J, Wittes J «The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.». N Engl J Med, 341, 10, 1999, pàg. 709-17. Arxivat de l'original el 2006-08-10. DOI: 10.1056/NEJM199909023411001. PMID: 10471456 [Consulta: 31 agost 2019].
«Advisory Statement». Klinge Chemicals / LoSalt. Arxivat de l'original el 2006-11-15. [Consulta: 15 març 2007].